William D. Young
CIK: 0001217420
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 29, 2026AUTL
Autolus Therapeutics plc
Award(A)DirectRestricted Share Units
31.7K shares- - Jun 29, 2026AUTL
Autolus Therapeutics plc
Award(A)DirectShare Option (Right to Buy)
47.5K shares- - Jun 10, 2026PRAX
Praxis Precision Medicines, Inc.
Award(A)Direct1.4K shares- - Jun 26, 2025PRAX
Praxis Precision Medicines, Inc.
Award(A)DirectStock Option (Right to Buy)
10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 |  AUTL Autolus Therapeutics plc | Award(A) Restricted Share Units | 31,667 | - | - | Direct |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Award(A) Share Option (Right to Buy) | 47,500 | - | - | Direct |
| Jun 10, 2026 |  PRAX Praxis Precision Medicines, Inc. | Award(A) | 1,371 | - | $0 | Direct |
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | Award(A) Stock Option (Right to Buy) | 10,520 | - | - | Direct |
1-4 of 4 transactions
About YOUNG WILLIAM D
YOUNG WILLIAM D (SEC CIK 0001217420) files insider reports with the SEC as Director of Autolus Therapeutics plc (AUTL) and Director of Praxis Precision Medicines, Inc. (PRAX).
Signal8 holds 4 ownership filings by YOUNG WILLIAM D (1 Form 3, 3 Form 4), filed between Jun 27, 2025 and Jul 1, 2026. Those filings report 4 transactions, from Jun 26, 2025 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on YOUNG WILLIAM D's filings is in LONDON.
Recent filings by YOUNG WILLIAM D
Other insiders filing for Autolus Therapeutics plc (AUTL)
- Piccina Cintia, U.S. CCO & Country Gen Manager
- Rao Madduri Ravin, Director
- Richardson Ryan, Director
- Leiderman Elisabeth, Director
- Iannone Robert, Director
- BUTITTA CYNTHIA M, Director